Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

To evaluate the efficacy and safety of Ergoferon in combination with symptomatic therapy in children from 6 months to 6 years old with acute respiratory infections (ARI) in contemporary outpatient practice, an international, multicenter, double-blind, placebo-controlled, randomized, parallel-group c...

Descripción completa

Detalles Bibliográficos
Autores principales: Geppe, N. A., Blokhin, B. M., Shamsheva, O. V., Abdrakhmanova, S. T., Alikhanova, K. A., Myrzabekova, G. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608533/
https://www.ncbi.nlm.nih.gov/pubmed/34820034
http://dx.doi.org/10.1155/2021/5570178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608533/
https://www.ncbi.nlm.nih.gov/pubmed/34820034
http://dx.doi.org/10.1155/2021/5570178

Ejemplares similares